Skip Ribbon Commands
Skip to main content
Navigate Up
Sign In
 
 

 Latest News

 
4/15/2014
The risks of BSIs vary according to the type of parental nutrition provided. The safest approach, consisting of ready-to-use three-chamber bag (MCB), was also shown to be essentially cost neutral.
4/10/2014
For oral medications with restrictions, understanding physician and patient knowledge gaps is critical to ensuring patients receive appropriate medication directions.
4/4/2014
​BETHESDA, MD, USA. April 2, 2014 -- Pharmerit International is pleased to announce the recent publication of a research paper conducted by Pharmerit International authors Caitlyn Solem
3/24/2014
A systematic literature review on the prevalence, measurement methods, consequences and risk factors for non-adherence to BCR-ABL inhibitors and adherence-enhancing interventions.
3/10/2014
Clinical Therapeutics published study on systolic blood pressure, in which Phamerit made a significant contribution.
1/27/2014
The Journal of Medical Decision Making will feature a Pharmerit study on modelling individual components of a combined endpoint.
10/18/2013
We have enjoyed meeting you at the 16th European ISPOR conference in Dublin, November 2013.
9/5/2013
Journal of Medical Economics (September 2013) publishes Pharmerit´s cost-effectiveness study on adjuvant therapy to prevent gastrointestinal stromal tumour recurrence.
6/26/2013
England and Wales’ National Institute for Health and Care Excellence (NICE) has positively reviewed the pharmaco-economic submission by the manufacturer of ocriplasmin (Jetrea®).
5/1/2013
Publication on alpha-blocker and anti-muscarinic combination treatment has been positively reviewed by the NHS Centre for Reviews and Dissemination (CRD).
Contact Feel free to contact us if you have any questions